After making a splash in the U.K. earlier this year, GSK is laying out plans for its biggest U.S. manufacturing investment ...

Big Pharma firm GSK plans to invest up to $800 million to expand its manufacturing operations in Pennsylvania and create 200 ...

A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster ...

GSK plans to invest $800 million in its East Donegal Township vaccine packaging facility over the next four years in an ...

A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.

Hundreds of millions of dollars and hundreds of new jobs are coming to Lancaster County. Vaccine manufacturer GSK announced ...

GSK (GSK) plc announced what it calls its “largest U.S. manufacturing investment to date.” The up to $800M investment will bring ...

GSK (GSK) plc announced what it calls its ... product manufacturing capabilities to the company’s site in Marietta, Pennsylvania, along with over 200 new jobs, the company stated.

GlaxoSmithKline, the London-based pharmaceutical giant with a substantial presence in Montgomery County and Philadelphia, announced a landmark investment ...

Earlier this year, GSK said it would invest £200 million (around $260 million) in upgrades to its manufacturing network in the UK, including a revamp of a plant in Melrose, Scotland, used to make ...

Global biopharma company GSK is investing up to $800 million in Pennsylvania and expanding its facility in Lancaster County.